Literature DB >> 2766866

In vitro activity of multiple antimicrobial combinations against Pseudomonas cepacia isolates.

A Kumar1, R Wofford-McQueen, R C Gordon.   

Abstract

For 16 isolates of Pseudomonas cepacia from patients with cystic fibrosis, synergism was determined by the killing curve method, utilizing various combinations of antibiotics [ticarcillin (Ti), rifampin (Ri), tobramycin (To), imipenem (Im), ofloxacin (Of), polymyxin B (PB), and trimethoprim/sulfamethoxazole (S x T)]. All 16 isolates were resistant to Ti, To, Ri, and PB; 11 were sensitive to S x T, 13 were sensitive to Im, and 2 were sensitive to Of. The combination of Im/Ri was synergistic for 8 isolates. Several combinations (Ti/Ri/Im), (Ti/Im/To), (Ri/Im/To) also demonstrated synergism for these 8 isolates. The Im/Ri combination did not demonstrate synergism against the other 8 isolates. The Ti/Im/To combination was synergistic for 6 of these. The Ri/Im/To combination was synergistic for 5 and the Ti/Im/Ri combination was synergistic for 3. Synergism could also be demonstrated with several 4-drug combinations. This study suggests that multi-drug combinations may have a role in the treatment of P. cepacia infections if proven in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766866     DOI: 10.1159/000238678

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  1 in total

1.  Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia.

Authors:  D Peckham; S Crouch; H Humphreys; B Lobo; A Tse; A J Knox
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.